Beta Cell

Nonprofit pharmaceutical company Civica has released it's biosimilar version of Lantus long-acting insulin for $55 for a box of 5 pens—that's the list price it costs you to buy it without needing insurance, coupons, or patient assistance programs. We look at how a nonprofit business model can drastically lower prices for patients and governments. Things we talk about: More info about Civica insulin and CalRx Insulin CalRx Patient Advisory Council Charter Episode on insulin pricing Episode on co-pay cap laws 119th Congress pro-healthcare scorecard Support Beta Cell on Patreon.